CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Biodesix Targets 2028 Launch for Imaging-Based Lung Nodule Risk Test

By Public Technologies
  • Biodesix added digital diagnostics to its lung testing strategy, targeting a 2028 commercial launch for its first imaging-based lung nodule risk test.
  • Developed with Vanderbilt University and Vanderbilt Health, the test aims to improve lung cancer risk assessment alongside the Nodify Lung blood-testing portfolio.
  • Initial performance results will be presented at the RSNA annual meeting on December 3, 2026.
  • The prospective STRATIFY study is expected to begin in the fourth quarter of 2026, matching blood and imaging biomarkers with clinical outcomes.
  • The study will support clinical validation, reimbursement evidence and future multimodal diagnostic development.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biodesix Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610190600PRIMZONEFULLFEED9848106) on October 19, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk